
LBA10Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinum-based chemotherapy (PCh) plus bev
Fujiwara, K, Harter, P, Leary, A, Perol, D, Pignata, S, González-Martín, A, Petru, E, van Nieuwenhuysen, E, Colombo, N, Mäenpää, J, Selle, F, de Gregorio, N, Lorusso, D, Guerra Alia, E M, Lefeuvre-PleVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz446.009
Date:
November, 2019
Fichier:
PDF, 109 KB
2019